Boston Scientific (US:BSX) — Company Overview, News & Financial Data
Boston Scientific develops medical devices to improve patient outcomes across various interventional specialties globally.
BSXBoston Scientific
Company profile
About Boston Scientific
Boston Scientific (NYSE:BSX) is a global developer, manufacturer, and marketer of medical devices that are used in a broad range of interventional medical specialties. The company focuses on improving health outcomes for patients by providing solutions that address unmet medical needs in cardiovascular, digestive, respiratory, neurology, urology, and pelvic health conditions, among others. Boston Scientific engages in research and development to foster innovation in these areas, with a commitment to enhancing patient care through high-quality, high-performance solutions. Its projects span from next-generation stent systems to breakthrough technologies in neuromodulation and endoscopy. The overarching objective of Boston Scientific is to transform lives through innovative medical solutions that improve the health of patients around the world.
Snapshot
Public USOwnership
1979Year founded
43787Employees
Marlborough, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
United States
Products and/or services of Boston Scientific
- Pioneering the development of stents, advancing life-saving treatments for heart and circulatory disorders.
- Innovating in neuromodulation technology, offering solutions to manage chronic pain and movement disorders.
- Offering unique urology and pelvic health solutions to improve patients’ quality of life.
- Developing advanced endoscopy technologies to help diagnose and treat gastrointestinal conditions.
- Supplying state-of-the-art devices for rhythm and heart failure management, including defibrillators and pacemakers.
- Providing groundbreaking solutions in the field of interventional oncology and vascular procedures.
Boston Scientific executive team
- Mr. Michael F. MahoneyChairman, President & CEO
- Mr. Joseph M. FitzgeraldExecutive VP & Group President of Cardiology
- Mr. Arthur Crosswell ButcherExecutive VP and Group President of MedSurg & Asia Pacific
- Mr. Jonathan R. MonsonExecutive VP & CFO
- Mr. Paudie O'ConnorExecutive Vice President of Global Operations
- Ms. Emily M. WoodworthSenior VP, Global Controller & Chief Accounting Officer
- Mr. Vance R. Brown J.D.Senior VP, General Counsel & Corporate Secretary
- Mr. Adam SmithGeneral Manager of Global Sales & Marketing
- Ms. Miriam O'sullivanSenior VP & Chief Human Resources Officer
- Ms. Brenda BeckerSenior Vice President of Global Government Affairs